Repeated measurements and cross-over designs

por Raghavarao, Damaraju, Padgett, Lakshmi V
Publicado 2014

Ustekinumab in Paediatric Patients with Moderately to Severely Active Crohn’s Disease: Pharmacokinetics, Safety, and Efficacy Results from UniStar, a Phase 1 Study

por Rosh, Joel R, Turner, Dan, Griffiths, Anne, Cohen, Stanley A, Jacobstein, Douglas, Adedokun, Omoniyi J, Padgett, Lakshmi, Terry, Natalie A, O’Brien, Christopher, Hyams, Jeffrey S
Publicado 2021

Maintenance of Efficacy and Continuing Safety of Golimumab for Active Ulcerative Colitis: PURSUIT-SC Maintenance Study Extension Through 1 Year

por Gibson, Peter R, Feagan, Brian G, Sandborn, William J, Marano, Colleen, Strauss, Richard, Johanns, Jewel, Padgett, Lakshmi, Collins, Judith, Tarabar, Dino, Hebzda, Zbigniew, Rutgeerts, Paul, Reinisch, Walter
Publicado 2016

Maintenance Golimumab Treatment in Pediatric UC Patients With Moderately to Severely Active UC: PURSUIT PEDS PK Long-Term Study Results

por Hyams, Jeffrey S, O’Brien, Christopher D, Padgett, Lakshmi, Rosh, Joel R, Turner, Dan, Veereman, Genevieve, Griffiths, Anne M, Heyman, Melvin B, Wahbeh, Ghassan, Adedokun, Omoniyi J, Strauss, Richard S, Lynch, John P, Chan, Daphne
Publicado 2020